Human Equilibrative Nucleoside Transporter 1 (hENT1) in Pancreatic Adenocarcinoma: Towards Individualized Treatment Decisions.
about
Immunohistochemical hENT1 expression as a prognostic biomarker in patients with resected pancreatic ductal adenocarcinoma undergoing adjuvant gemcitabine-based chemotherapy.Nanomedicine strategies to overcome the pathophysiological barriers of pancreatic cancer.Enhancing Drug Efficacy and Therapeutic Index through Cheminformatics-Based Selection of Small Molecule Binary Weapons That Improve Transporter-Mediated Targeting: A Cytotoxicity System Based on Gemcitabine.Membrane Localization of Human Equilibrative Nucleoside Transporter 1 in Tumor Cells May Predict Response to Adjuvant Gemcitabine in Resected Cholangiocarcinoma PatientsPancreatic cancer - cost for overtreatment with gemcitabine.Pharmacological factors affecting accumulation of gemcitabine's active metabolite, gemcitabine triphosphate.Time and concentration dependency of P-gp, MRP1 and MRP5 induction in response to gemcitabine uptake in Capan-2 pancreatic cancer cells.Emerging antibodies for the treatment of pancreatic cancer.An integrative network inference approach to predict mechanisms of cancer chemoresistance.Novel regulation of equlibrative nucleoside transporter 1 (ENT1) by receptor-stimulated Ca2+-dependent calmodulin binding.Case of Six-Year Disease-Free Survival with Undifferentiated Carcinoma of the Pancreas.
P2860
Q30238470-D5CCFBA5-21F5-4E10-BAC5-D49518DB2A82Q34537580-27AF1909-26C6-4EC3-AF69-638C457F56A8Q36342657-2E2AA84D-765D-4E95-8D56-5BA6A6A3AD79Q36884377-82A190E1-494C-47FD-A025-EA4735A8B9BAQ38067828-68874EB5-5D9A-4273-A35A-6E50EF93DF13Q38673319-A0B896C5-59C3-40BE-99FD-5B7D197DA407Q38922511-7502EB7A-79CF-478A-B14D-3C9CB8C7644CQ39158427-3D834388-19AC-45BC-A024-8CB054E3A343Q39206497-47C4F565-5041-4CA6-B691-59022BB5E1CEQ39892650-0C8875A0-06B0-484A-AEA9-DEFE8191FCEDQ41237372-2A5C8F39-E7C4-451D-8275-34066B5460E5
P2860
Human Equilibrative Nucleoside Transporter 1 (hENT1) in Pancreatic Adenocarcinoma: Towards Individualized Treatment Decisions.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 02 December 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Human Equilibrative Nucleoside ...... idualized Treatment Decisions.
@en
type
label
Human Equilibrative Nucleoside ...... idualized Treatment Decisions.
@en
prefLabel
Human Equilibrative Nucleoside ...... idualized Treatment Decisions.
@en
P2860
P356
P1433
P1476
Human Equilibrative Nucleoside ...... vidualized Treatment Decisions
@en
P2093
Jennifer L Spratlin
P2860
P304
P356
10.3390/CANCERS2042044
P577
2010-12-02T00:00:00Z